CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a large decrease in short interest in the month of March. As of March 31st, there was short interest totaling 1,357 shares, a decrease of 14.8% from the March 15th total of 1,593 shares. Based on an average daily volume of 6,452 shares, the short-interest ratio is currently 0.2 days.
CSPC Pharmaceutical Group Trading Down 1.5%
Shares of CSPCY opened at C$4.60 on Friday. CSPC Pharmaceutical Group has a fifty-two week low of C$2.73 and a fifty-two week high of C$5.83. The business’s 50-day moving average is C$4.80 and its 200-day moving average is C$4.53.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
Featured Stories
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
